Changing Treatment Landscape of Metastatic Head and Neck Squamous Cell Carcinoma with Anti-PD-1/PD-L1 Agents – Enduring Webcast

Description

Program Description

---

This webcast is intended to improve care of patients with head and neck cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.

Intended Audience

---

This webcast is designed to meet the educational needs of hematologists/oncologists, physician assistants, nurse practitioners, registered nurses, pharmacists and fellows in training involved in the diagnosis and treatment of patients with head and neck cancer.

Commercial Supporters

---

Supported by Merck Sharpe & Dohme Corp.